| Product Code: ETC7635408 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Next Generation Cancer Diagnostics Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Next Generation Cancer Diagnostics Market - Industry Life Cycle |
3.4 Ireland Next Generation Cancer Diagnostics Market - Porter's Five Forces |
3.5 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F |
3.8 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F |
4 Ireland Next Generation Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing adoption of advanced diagnostic technologies |
4.2.3 Favorable government initiatives and funding for cancer research and diagnostics |
4.3 Market Restraints |
4.3.1 High costs associated with next-generation cancer diagnostics |
4.3.2 Limited access to advanced diagnostic technologies in certain regions of Ireland |
5 Ireland Next Generation Cancer Diagnostics Market Trends |
6 Ireland Next Generation Cancer Diagnostics Market, By Types |
6.1 Ireland Next Generation Cancer Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F |
6.1.4 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F |
6.1.5 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F |
6.1.6 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F |
6.1.7 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F |
6.2 Ireland Next Generation Cancer Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F |
6.2.3 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F |
6.2.4 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F |
6.2.5 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F |
6.2.6 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F |
6.3 Ireland Next Generation Cancer Diagnostics Market, By Cancer |
6.3.1 Overview and Analysis |
6.3.2 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.4 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.3.6 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Next Generation Cancer Diagnostics Market, By Function |
6.4.1 Overview and Analysis |
6.4.2 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F |
6.4.3 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.4.4 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F |
6.4.5 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F |
6.4.6 Ireland Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F |
7 Ireland Next Generation Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Ireland Next Generation Cancer Diagnostics Market Export to Major Countries |
7.2 Ireland Next Generation Cancer Diagnostics Market Imports from Major Countries |
8 Ireland Next Generation Cancer Diagnostics Market Key Performance Indicators |
8.1 Average turnaround time for diagnostic test results |
8.2 Rate of adoption of next-generation cancer diagnostic technologies |
8.3 Number of research collaborations and partnerships in the field of cancer diagnostics |
9 Ireland Next Generation Cancer Diagnostics Market - Opportunity Assessment |
9.1 Ireland Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ireland Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F |
9.4 Ireland Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F |
10 Ireland Next Generation Cancer Diagnostics Market - Competitive Landscape |
10.1 Ireland Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Ireland Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here